Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

17.08.2026

2 BMC Cancer
1 Eur J Obstet Gynecol Reprod Biol
3 Int J Gynecol Pathol
1 Oncogene
1 PLoS One



    BMC Cancer

  1. CHAI H, Pan C, Zhang M, Huo H, et al
    Retraction Note: Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.
    BMC Cancer. 2026;26:984.
    >> Share

  2. HACHISUGA K, Katayama Y, Inomata Y, Kawakami M, et al
    Tumor immune microenvironment and epithelial-mesenchymal transition in recurrence of low-grade stage IA endometrial endometrioid carcinoma.
    BMC Cancer. 2026 Jun 2. doi: 10.1186/s12885-026-16277.
    >> Share


    Eur J Obstet Gynecol Reprod Biol

  3. BAHCECI P, Ay O, Energin H
    Clinicopathologic prognostic factors and the role of adenomyosis in endometrial cancer: A 25-year single-center experience.
    Eur J Obstet Gynecol Reprod Biol. 2026;325:115284.
    >> Share


    Int J Gynecol Pathol

  4. HELLBERG P, Pasanen A, Simila-Maarala J, Butzow R, et al
    p53 Normal and p53 Abnormal Clear Cell Ovarian Carcinomas: Clinical Characteristics and Biomarker Profiles.
    Int J Gynecol Pathol. 2026;45:340-348.
    >> Share

  5. ALZAYADNEH E, Dibbern ME, Rabban J, Fadare O, et al
    HER2 and FOLR1 Expression in Mesonephric and Mesonephric-Like Adenocarcinomas in the Gynecologic Tract.
    Int J Gynecol Pathol. 2026;45:349-357.
    >> Share

  6. CHEN Q, Wei Z, Tang F
    Collision Tumor of the Uterine Corpus: Primary EBV-positive Diffuse Large B-Cell Lymphoma and Endometrioid Carcinoma.
    Int J Gynecol Pathol. 2026;45:412-417.
    >> Share


    Oncogene

  7. GUILBARD M, Taouji S, Aubry M, Robert J, et al
    Complementary intra- and extracellular AGR2 activities support epithelial ovarian cancer cell aggressiveness.
    Oncogene. 2026 Aug 10. doi: 10.1038/s41388-026-03938.
    >> Share


    PLoS One

  8. MAJUMDER R, Datta P, Moolayadukkam S, Puri IK, et al
    Repurposing Alzheimer's and ovarian cancer drugs as sonosensitizers for glioblastoma via a positive-unlabeled learning and 3D bioprinting-based new approach methodology (NAM).
    PLoS One. 2026;21:e0354981.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016